all bells and whistles here...casino jumped noodles? If you are referring to ndls, then they have missed earnings expectations 4 quarters in a row and have flat to negative YOY growth for each of the last 3 q's. If you are referring to ndls, then get out of it ASAP...you are looking for a mlb home run on a pee wee tee league for tots
no, but the price action continually tells one otherwise. Eventually there has to be a reality check, but the markets have been living in dreamland for so long, it just doesn't matter...until the music stops. There are certainly enough negative events going on domestically and globally to crash these markets at any time. People just keep on dancing and partying even though the house is on fire.
it's a coupon for a free burrito provided you buy a tofu sofrita first. This is their way of trying to offset the supplier deficiencies that just occurred due to the pork shortage.
scary for longs and shorts here...so many variables on the upcoming er and guidance that it's enough to make ones head spin. this stock is priced for perfection, but a solid q and guidance could easily blow this well into the 800's...the tiniest slip could easily send this to the low 600's. The worst case scenario for options players is a consensus earnings and muted response. Premiums on both sides would drop into the toilet and the option writers clean up. I'd love to see an early warning and drop this like a smoking hot burrito, but I am obviously biased. I think the company has a great product, great model, and terrific execution, but I believe the stock to be 40 percent higher than its' peers even with growth taken into account. GL to all players...we are only here to make money---we aren't changing the world.
there is a huge difference between market cap and cash reserves. Market cap is like a cloud...you can see it, but it has no substance.
If they sold 2 million shares of this stock....the price would be about $100-$200 less a share in a heartbeat.
actually...CMG has 31 million shares outstanding with $13/sh in earnings...this equates to $403 million in annual earnings. There is roughly 1600 stores....$403,000,000 divided by 1600 equals...$251,875 in profit per store. On top of that...even if you wished to own a franchise, you couldn't. CMG stores are all company owned.
i guess i'll say what only all of us can say...we'll see...we'll see? Besides, the company knew they were diluting the company for the directors benefit...if they tried to raise cash at or near the same time it would have been a disaster.
you are correct, again, where is this company with that process right now? All this supposed activity, and nary a peep of substantial info to investors. At a time when the business is finally showing promise, the PR department tells no story and generates no buzz. They shouldn't feel the need to be frightened of upsetting the regulators any more---they should communicate to he regulators that they wish to actively promote this stock and get the share price moving, or at least stimulate liquidity in the form of volume. They would then be no different than any other listed entity.
Let me be proactive here, before you wrongly attack me again poo...I believe the vitiligo therapy will be the golden goose for this company and that the EPP revenues will allow us to get there. I, nor anyone else for that matter, has any idea what the revs will be over the next few years, what the burn rate for the company will be, and how long can this company stay solvent before vitiligo therapy can achieve market approval. Will we need another significant cash infusion/dilution to get there? At these prices, it will be a double negative for investors. Obviously, a higher share price eases the burden for the company and its' investors during a capital raising. Low single digits is an albatross for the future of this company. I just see what everyone else sees....nothing in the form of hard line communication, data, or information. As an investor, I just want to be informed and feel like I'm in the loop, in the light so to speak, and not in the dark. If PW is the financial guru he claims to be, then he should have friends in high places in the financial community that can get this share price up. The prospects alone should have garnered interest....where is this interest? The sooner the better for a rise in the SP imo, because this is a very financially poor company that will need capital going forward. If we are entering a bearish phase in the global financial markets, the sledding will only become more difficult.
If the global markets do fall apart, I would hope this finds a bottom at $2. I'm wondering why mgmt has gone on vacation and decided that informing investors of current events within this company is a needless area to address. 3 months since approval and the only news of substance has been the compensation package for the board of directors. What is the expected burn rate going forward during the marketing and rollout of scenesse? What, if any, progress has been made with insurers within the EU? When do they expect the first true sales to be booked? There has literally been nothing coming from the company's lips to investors about hard timelines or pertinent information relating to the progression towards actual revenues. I just think that is way beyond irresponsible, it's ignorant.
where do people get the idea that this is going to be nasdaq listed? If that is true, then it they need to meet a minimum of one of the many standards that nasdaq has, and so far, clinuvel has not met a single criteria for nas endorsement. Someday it will be eligible, but the share price is not far off from pre-approval pricing. There are many companies out there with good prospects, but the stocks are complete dogs...this is definitely one of them. Couldn't advance in the largest historical bull market ever and the greatest ever bull market for biotech within this bull market even with an approval granted for a novel pharmaceutical product. What more does a company have to do just to get a little love? Now we are entering an obvious bear market that could rival the most recent one, and make 2009 look like a picnic at the beach. The long, grinding, fruitless wait continues...what will be the catalyst for a northerly move? The markets are supposed to look 6 months ahead, and biotechs are historically priced a few years ahead. Big sighs!
hah!...you sir, are most likely correct, In any past bouts of volume, it has started with a small increase which led up to 6 figures....if there is any chance of this pattern repeating, we should see something over 50 k tonight...otherwise, it will be a UFO as you so incisively described it.
is there an actual glimmer of volume tonight on the asx...about twice its recent average. Better than the 17,000-21,000 this has been getting lately. Volume is everything and this stock needs it bad.
I'm fully long...I've been invested in clinuvel since the epitan days and have added every year. Where do i see the stock in 2015/2016? I have no idea because i have been wrong about where this stock should be for 10 years now. There has been essentially no movement in this despite the positives...I refuse to hazard a guess because it seems fruitless to do so. This stock could be at $4 in 2015/2016 or it could be at $10 in 2015/2016. If this catches the eye of the media and momentum traders, fundamentals won't matter---this will shoot up like all momo stocks. Currently, this is in the dark and when the lights come on is anyone's guess and nobody's conviction. The stock has never showed anything yet, past or present, so to hypothesize with no credible history to base any future moves on seems redundant. Volume will tell the story, and any volume this briefly had has long since faded away.
there has not been one single insurance company in the European Union that has indicated on any level what they are willing to reimburse EPP patients for Scenesse and whether they will reimburse at all. _Not counting Switzerland and Italy) Each country will have their own parameters for reimbursement I believe. Based on this simple fact along with a complete lack of any hard data on how many EPP patients will participate (largely hinges on reimbursement potential from insurance companies),,,I find it incredibly arrogant for anyone to start making concrete prediction of annual participants, revenue streams, and earnings with actual dates mind you. That is not an educated guess by any means, it is nothing but a foolish attempt at wishful thinking. Please reserve your ludicrous convictions until some actual hard evidence comes out. We aren't even at step 1 and you are posting projections for step 5. I'm not in any way, shape or form a plant. I am trying to be pragmatic versus an insidious pumper like yourself. I have made projections in the past and realize how foolish it was to do so. I will wait until something develops with the agencies involved before I make another future judgement on this company. This microcap is treading some very thin ice until they can start creating some real value to help fend off the wolves and to protect their "proprietary" position in the field of melanocortins. There are countless mega-billion dollar pharmaceutical companies out there that could and will eat our lunch if they see serious profits to be made. Let this company try to make a single dollar before you parade around profitability dates.
there is a 90 percent chance of getting headaches and nausea from watching this stock in conjunction with a combination therapy of reading the numerous associated message boards.
that's pretty funny..most of you don't have a clue what a bear market is and what happens to stock prices during one. Deflation isn't a word used just for the global economies...it also pertains to bloated stocks. If you can't see the writing on the wall this time, then you have no one to blame but yourself.
what's 50 percent of $3.30? I'll clue you in...it's $1.65 and the 52 week high is $5....that is over 50 percent higher than the current price. When investing, the percentage it takes to drop a stock is always less than the percentage it takes to rise. If a stock drops 50 percent, then it need to rise 100 percent to reclaim that same value. You always nitpick my comments---thanks for skewing the facts once again. Peace